Every one of those 1 sits in a single category, medical-devices. ADMA Biologics, Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 4 original sources each. ASCENIV appears in 1 tracked Healthcare story from July 12, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about ASCENIV
Every one of those 1 sits in a single category, medical-devices. ADMA Biologics, Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 4 original sources each. ASCENIV appears in 1 tracked Healthcare story from July 12, 2026.
Stories tracked
1
Sources per story
4
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering ASCENIV. Shared-story counts are live from our verified record — not editorial picks.
Medical device makers Insulet and Embecta face class actions alleging hidden defects and demand weaknesses for insulin delivery products, causing steep investor losses.
ASCENIV is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.